GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,628 | -30.7% | 10,192 | +0.5% | 0.00% | – |
| Q2 2023 | $55,765 | +27.8% | 10,139 | -8.7% | 0.00% | – |
| Q4 2022 | $43,635 | -19.2% | 11,103 | +8.3% | 0.00% | – |
| Q3 2022 | $54,000 | -47.6% | 10,251 | -27.4% | 0.00% | – |
| Q1 2022 | $103,000 | -16.9% | 14,115 | -19.6% | 0.00% | – |
| Q4 2021 | $124,000 | -72.1% | 17,558 | -1.0% | 0.00% | -100.0% |
| Q3 2021 | $445,000 | -23.1% | 17,744 | -17.6% | 0.00% | -50.0% |
| Q2 2021 | $579,000 | +11.1% | 21,542 | +17.6% | 0.00% | 0.0% |
| Q1 2021 | $521,000 | +85.4% | 18,312 | +85.0% | 0.00% | +100.0% |
| Q4 2020 | $281,000 | – | 9,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |